Skip to content
10-Q

Quarterly Report

Lantern Pharma Inc. LTRN

0001493152-25-021927

← back to feed
Filed
Nov 12, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 5, 2025 11.18M sh
Shares Diluted Q3 2025 · Sep 30, 2025 10.83M sh
Shares Diluted Q3 2025 · Sep 30, 2025 10.8M sh
Shares Diluted Q3 2025 · Sep 30, 2024 10.76M sh
Shares Diluted Q3 2025 · Sep 30, 2024 10.76M sh
Capex Q3 2025 · Sep 30, 2025 $1.71K
Capex Q3 2025 · Sep 30, 2024 $9.51K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$12.88M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$13.84M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $8.39M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $7.51M
Stockholders Equity Q3 2025 · Sep 30, 2025 $9.59M
Stockholders Equity Q3 2025 · Jun 30, 2025 $12.52M
Stockholders Equity Q3 2025 · Mar 31, 2025 $16.78M
Stockholders Equity Q3 2025 · Dec 31, 2024 $21.19M
Stockholders Equity Q3 2025 · Sep 30, 2024 $26.6M
Stockholders Equity Q3 2025 · Jun 30, 2024 $30.93M
Stockholders Equity Q3 2025 · Mar 31, 2024 $35.77M
Stockholders Equity Q3 2025 · Dec 31, 2023 $40.91M
Current Liabilities Q3 2025 · Sep 30, 2025 $4.04M
Current Liabilities Q3 2025 · Dec 31, 2024 $4.33M
Total Liabilities Q3 2025 · Sep 30, 2025 $4.04M
Total Liabilities Q3 2025 · Dec 31, 2024 $4.38M
Current Assets Q3 2025 · Sep 30, 2025 $13.46M
Current Assets Q3 2025 · Dec 31, 2024 $25.25M
Total Assets Q3 2025 · Sep 30, 2025 $13.63M
Total Assets Q3 2025 · Dec 31, 2024 $25.57M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.39
Eps Diluted Q3 2025 · Sep 30, 2025 −$1.21
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.42
Eps Diluted Q3 2025 · Sep 30, 2024 −$1.39
Eps Basic Q3 2025 · Sep 30, 2025 −$0.39
Eps Basic Q3 2025 · Sep 30, 2025 −$1.21
Eps Basic Q3 2025 · Sep 30, 2024 −$0.42
Eps Basic Q3 2025 · Sep 30, 2024 −$1.39
Sga Expense Q3 2025 · Sep 30, 2025 $1.91M
Sga Expense Q3 2025 · Sep 30, 2025 $5.01M
Sga Expense Q3 2025 · Sep 30, 2024 $1.46M
Sga Expense Q3 2025 · Sep 30, 2024 $4.46M
Rd Expense Q3 2025 · Sep 30, 2025 $2.44M
Rd Expense Q3 2025 · Sep 30, 2025 $8.77M
Rd Expense Q3 2025 · Sep 30, 2024 $3.72M
Rd Expense Q3 2025 · Sep 30, 2024 $11.86M
Net Income Q3 2025 · Sep 30, 2025 −$4.18M
Net Income Q3 2025 · Sep 30, 2025 −$13.05M
Net Income Q3 2025 · Jun 30, 2025 −$4.33M
Net Income Q3 2025 · Mar 31, 2025 −$4.54M
Net Income Q3 2025 · Sep 30, 2024 −$4.51M
Net Income Q3 2025 · Sep 30, 2024 −$14.91M
Net Income Q3 2025 · Jun 30, 2024 −$4.96M
Net Income Q3 2025 · Mar 31, 2024 −$5.44M
Operating Income Q3 2025 · Sep 30, 2025 −$4.35M
Operating Income Q3 2025 · Sep 30, 2025 −$13.78M
Operating Income Q3 2025 · Sep 30, 2024 −$5.18M
Operating Income Q3 2025 · Sep 30, 2024 −$16.32M